Company: NIVFW
Filing Date: 2025-08-21
Form Type: DRS
Source: 0001213900-25-079301
Chunk: 222

Company: NewGenIvf Group Ltd
Filing Date: 2025-08-21
Form: DRS
Chunk 222
---
1,100,000 |     |            | 0.830 |     |        | 14.75 | % |     | August 3, 2024    |     | February 2, 2029 |
| JAK & affiliated holders |     |           |   500,000 |     |            | 0.950 |     |        | 14.75 | % |     | August 30, 2024   |     | March 1, 2029    |
| JAK & affiliated holders |     |           | 1,500,000 |     |            | 0.686 |     |        | 14.75 | % |     | November 11, 2024 |     | May 10, 2029     |
| Total                    |     |           | 3,150,000 |     |            |       |     |        |       |   |     |                   |     |                  |

During the year ended December
31, 2024, a total of $5,800,000 of convertible promissory notes were issued with a discount of 7%. These Notes are to be settled by way
of cash or may be converted to Class A ordinary shares. The conversion of these notes are subject to certain criterions as mentioned
in the Convertible Note Agreements, which include a beneficiary cap of 9.9% of shareholdings in the Company by JAK.

<div align='center'>F-22</div>

As of December 31, 2024,
$2,650,000 of convertible notes were converted into 7,020,975 ordinary shares (equivalent to 35,105 post Reverse Stock Splits) by the
note holder, thereby increasing our shareholder equity by the same amount.

The effective interest expense
calculated at 16.96 % amounted to $765,177 and $nil for the year ended December 31, 2024 and December 31, 2023 respectively.

The transaction costs incurred
on issuance of the Notes are capitalized and amortised over the term of the Notes as follows:

| Transaction                      
 costs on issuance of Notes       |     | December 31, 
 2024         |          |   |     | 2023 |   |
|:---------------------------------|:----|:-------------|---------:|:--|:----|:-----|:--|
| Balance at beginning of the year |     | $